Oral diseases cost Americans almost $140 billion annually. What will it take to bring these costs down? The post If We Treated Tooth Decay Like We Treat Heart Disease, We’d Save Billions appeared first on MedCity News.
KFF Health News chief Washington correspondent Julie Rovner discussed how cuts to Medicaid in President Donald Trump’s megabill will affect Americans’ access to health care on NPR’s “Up First,” CNN’s “CNN This Morning” and WNYC’s “The Brian Lehrer Show” on July 2. Rovner also discussed U.S. domestic and global vaccine policy on WAMU’s “1A” on July…
Healthcare CEOs and founders, it’s time to step up. We need greater oversight and transparency in the digital supplement space to protect consumers from harm. The post The Digital Supplement Mess: Are We Sacrificing Patient Safety for Clickthrough Rates? appeared first on MedCity News.
Here are nine notable announcements shared at the HLTH conference held this week in Las Vegas. The post 9 HLTH Announcements You Don’t Want to Miss appeared first on MedCity News.
Robert Krayn is the CEO and & Dr. Georgia Caveras the CMO of Talkiatry. Robert and Georgia are quite the dynamic duo (she says, “He’s the money I’m the medicine!”). As a relative latecomer in the online mental health world, Talkiatry is trying to differentiate itself from the other big players like Lyra, Headspace, Brightside…
Last week, CMS announced the GENEROUS (GENErating cost Reductions fOr U.S. Medicaid) Model. The program basically is a ‘most favored nation’ style reference pricing based on net prices from developed countries. The program builds on the Medicaid Drug Rebate Program (MDRP). Specific details specified on the CMS website include: Participating manufacturers whose applications are accepted…
[Sponsored] This year, the survey includes new focus areas — ROI reporting, the value of clinical expertise, and evolving expectations around cost and care optimization. The post Consultants to Self-Insured Employers: Share Your Experience and Perspective in This New Survey appeared first on MedCity News.
By MATTHEW HOLT It was not so long ago that you could create one of those maps of health care IT or digital health and be roughly right. I did it myself back in the Health 2.0 days, including the old sub categories of the “Rebel Alliance of New Provider Technologies” and the “Frontier of…
The FDA will provide faster regulatory review of generic drugs that are tested in and manufactured in the U.S. using domestically sourced active pharmaceutical ingredients. This FDA pilot program is part of a broader Trump administration strategy to reshore pharmaceutical production. The post FDA Pilot Program Creates New Path for Faster Regulatory Review of Generic…
Executives say acuity and utilization trends continue to hurt but they’re seeing positive signs when it comes to disenrollment as well as a “greater receptivity” from state officials about rates and plan design changes.